Bayesian Capital Management’s Crown Holdings CCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,590
Closed -$2.38M 188
2025
Q3
$2.38M Buy
+24,590
New +$2.47M 0.49% 49
2025
Q2
Sell
-23,369
Closed -$2.09M 582
2025
Q1
$2.09M Buy
23,369
+11,800
+102% +$1.03M 0.35% 78
2024
Q4
$957K Buy
+11,569
New +$1.05M 0.12% 235
2023
Q4
Sell
-7,040
Closed -$623K 779
2023
Q3
$623K Buy
+7,040
New +$631K 0.07% 324
2022
Q2
Sell
-2,343
Closed -$293K 811
2022
Q1
$293K Buy
+2,343
New +$277K 0.04% 532
2021
Q4
Sell
-7,124
Closed -$718K 394
2021
Q3
$718K Sell
7,124
-3,476
-33% -$365K 0.21% 131
2021
Q2
$1.08M Buy
+10,600
New +$1.12M 0.28% 94
2021
Q1
Sell
-3,800
Closed -$381K 549
2020
Q4
$381K Buy
+3,800
New +$349K 0.1% 258
2020
Q2
Sell
-4,700
Closed -$273K 548
2020
Q1
$273K Buy
4,700
+500
+12% +$34.8K 0.06% 493
2019
Q4
$305K Buy
+4,200
New +$300K 0.05% 422
2018
Q1
Sell
-9,700
Closed -$546K 604
2017
Q4
$546K Buy
+9,700
New +$574K 0.11% 295
2016
Q1
Sell
-5,197
Closed -$263K 362
2015
Q4
$263K Buy
+5,197
New +$265K 0.38% 123

Other funds holding CCK

Bayesian Capital Management's CCK Position: Q4 2025 in Review

Bayesian Capital Management sold out of Crown Holdings (CCK) in Q4 2025, closing a stake of 24,590 shares — an estimated $2.38M sold.

Bayesian Capital Management first reported a position in CCK in Q4 2015 and held it in 12 quarters. The position peaked at $2.38M in Q3 2025. 646 funds tracked by Wall St. Rank hold CCK as of Q4 2025.

  • Bayesian Capital Management reported no remaining Crown Holdings position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 24,590 Crown Holdings shares in Q4 2025, an estimated $2.38M.
  • Bayesian Capital Management first reported a position in Crown Holdings in Q4 2015 and held it in 12 quarters.
  • Bayesian Capital Management's Crown Holdings position peaked at $2.38M in Q3 2025.
  • 646 funds tracked by Wall St. Rank held Crown Holdings as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.